Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 11 studies | 24% ± 7% | |
basal cell | 5 studies | 19% ± 2% | |
club cell | 4 studies | 30% ± 11% | |
secretory cell | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of RASSF9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 91% | 284.28 | 164 / 180 | 99% | 17.40 | 427 / 430 |
lung | 99% | 531.00 | 570 / 578 | 77% | 13.30 | 893 / 1155 |
esophagus | 98% | 512.65 | 1422 / 1445 | 73% | 10.31 | 134 / 183 |
uterus | 99% | 523.29 | 169 / 170 | 63% | 7.66 | 287 / 459 |
pancreas | 89% | 194.31 | 291 / 328 | 72% | 3.54 | 129 / 178 |
prostate | 96% | 341.40 | 234 / 245 | 51% | 1.97 | 254 / 502 |
breast | 97% | 417.25 | 447 / 459 | 38% | 1.67 | 422 / 1118 |
kidney | 98% | 337.25 | 87 / 89 | 34% | 1.78 | 309 / 901 |
thymus | 100% | 657.24 | 652 / 653 | 29% | 1.53 | 173 / 605 |
stomach | 82% | 160.57 | 293 / 359 | 35% | 1.68 | 99 / 286 |
bladder | 90% | 196.43 | 19 / 21 | 22% | 1.98 | 112 / 504 |
intestine | 82% | 213.80 | 788 / 966 | 28% | 1.31 | 145 / 527 |
spleen | 100% | 304.00 | 240 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 490.39 | 1312 / 1335 | 0% | 0 | 0 / 0 |
skin | 89% | 339.60 | 1602 / 1809 | 8% | 0.37 | 39 / 472 |
heart | 97% | 332.65 | 831 / 861 | 0% | 0 | 0 / 0 |
adipose | 96% | 531.77 | 1157 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 85% | 242.63 | 220 / 258 | 9% | 0.42 | 20 / 230 |
tonsil | 0% | 0 | 0 / 0 | 82% | 12.42 | 37 / 45 |
muscle | 80% | 152.43 | 643 / 803 | 0% | 0 | 0 / 0 |
liver | 36% | 46.51 | 82 / 226 | 17% | 2.26 | 71 / 406 |
brain | 21% | 80.92 | 544 / 2642 | 13% | 2.07 | 89 / 705 |
peripheral blood | 0% | 0.14 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0016197 | Biological process | endosomal transport |
GO_0046907 | Biological process | intracellular transport |
GO_0006605 | Biological process | protein targeting |
GO_0012510 | Cellular component | trans-Golgi network transport vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005768 | Cellular component | endosome |
GO_0005829 | Cellular component | cytosol |
GO_0055037 | Cellular component | recycling endosome |
GO_0005515 | Molecular function | protein binding |
Gene name | RASSF9 |
Protein name | Ras association domain-containing protein 9 (PAM COOH-terminal interactor protein 1) (P-CIP1) (Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor) |
Synonyms | PAMCI PCIP1 |
Description | FUNCTION: May play a role in regulating vesicuar trafficking in cells. . |
Accessions | ENST00000361228.5 O75901 |